Solventum Corp | SOLV - Cash And Equivalent


Solventum Corp reported $451M in Cash and Equivalent for its fiscal quarter ending in September of 2026.





Cash And Equivalent Change Date
Abbott USD 4.05B 1.05B Sep/2026
Align Technology USD 1.1B 42.76M Jun/2026
Baxter International USD 1.98B 175M Sep/2026
Becton, Dickinson and Co. USD 725M 17M Sep/2026
Cencora USD 2.82B 638.79M Jun/2026
Dexcom USD 961.4M 143.6M Sep/2026
Insulet USD 584.4M 49.5M Sep/2026
Solventum Corp USD 451M 48M Sep/2026
West Pharmaceutical Services USD 464.1M 28.3M Sep/2026
Zimmer Biomet Holdings USD 399.9M 10.1M Sep/2026